Serum and cerebrospinal fluid human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP) in intracranial germ cell tumors.
We report a retrospective study on serum and cerebrospinal fluid (CSF) alpha-fetoprotein (AFP) and beta-human chorionic gonadotropin (betahCG) determination in a series of 30 patients bearing intracranial germ cell tumors. At diagnosis five patients had high serum and CSF AFP levels. No patient had positive serum AFP and negative CSF AFP or vice versa. Twelve of 30 patients had serum betahCG levels above 5 mlU/mL, eight had high betahCG only in CSF, and ten were completely negative. During treatment and follow-up both markers were accurate indicators of the response to therapy, decreasing rapidly and often becoming normal already after the first phase of treatment. We conclude that these two markers, and mostly betahCG, may be useful in the diagnosis and monitoring of the response to therapy of patients with intracranial germ cell tumors.
RIA Laboratory, Nuclear Medicine Division, Istituto Nazionale per la Studio e la Cura dei Tumori, Milan, Italy.
E
E
Seregni
M
M
Massimino
S
S
Nerini Molteni
F
F
Pallotti
B
B
van der Hiel
G
G
Cefalo
F
F
Spreafico
F
F
Fossati
E
E
Bombardieri
D000293:Adolescent; D000328:Adult; D001932:Brain Neoplasms / Q000737:chemistry*; D002648:Child; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000032:analysis* / Q000097:blood / Q000134:cerebrospinal fluid; D005260:Female; D018237:Germinoma / Q000737:chemistry*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D000509:alpha-Fetoproteins / Q000032:analysis* / Q000134:cerebrospinal fluid
D018997:Chorionic Gonadotropin, beta Subunit, Human; D000509:alpha-Fetoproteins